Neuronal morphology in MeCP2 mouse models is intrinsically variable and depends on age, cell type, and Mecp2 mutation

Neurobiology of Disease

Volumn 58, Issue , 2013, Pages 3-12

  Wang, I Ting J ^a   Reyes, Arith Ruth S ^a   Zhou, Zhaolan ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Dendritic branching; MECP2; Mouse model; Neuronal morphology; Rett syndrome; Soma size

Indexed keywords

METHYL CPG BINDING PROTEIN 2;

AGE; ANIMAL EXPERIMENT; ANIMAL HUSBANDRY; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRANCHING MORPHOGENESIS; CELL TYPE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; GENE; GENE DUPLICATION; GENE MUTATION; GENETIC TRANSCRIPTION; HETEROZYGOSITY; IN VIVO STUDY; MALE; MECP2 GENE; MISSENSE MUTATION; MORPHOLOGY; MOUSE; NERVE CELL; NERVE FIBER GROWTH; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RELIABILITY; RETT SYNDROME; SOMATOSENSORY CORTEX;

DENDRITIC BRANCHING; MECP2; MOUSE MODEL; NEURONAL MORPHOLOGY; RETT SYNDROME; SOMA SIZE;

AGING; ANALYSIS OF VARIANCE; ANIMALS; BRAIN; DENDRITES; DISEASE MODELS, ANIMAL; GREEN FLUORESCENT PROTEINS; METHYL-CPG-BINDING PROTEIN 2; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MICROSCOPY, CONFOCAL; MUTATION; NEURONS; RETT SYNDROME;

EID: 84878478934     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2013.04.020     Document Type: Article

References (56)

1. Amir R.E., Van Den Veyver I.B., Wan M., Tran C.Q., Francke U., Zoghbi H.Y. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat. Genet. 1999, 23:185-188.
2. Armstrong D.D. Neuropathology of Rett syndrome. J. Child Neurol. 2005, 20:747-753.
3. Armstrong D., Dunn J.K., Antalffy B., Trivedi R. Selective dendritic alterations in the cortex of Rett syndrome. J. Neuropathol. Exp. Neurol. 1995, 54:195-201.
4. Bauman M.L., Kemper T.L., Arin D.M. Pervasive neuroanatomic abnormalities of the brain in three cases of Rett's syndrome. Neurology 1995, 45:1581-1586.
5. Belichenko P.V., Oldfors A., Hagberg B., Dahlström A. Rett syndrome: 3-D confocal microscopy of cortical pyramidal dendrites and afferents. Neuroreport 1994, 5:1509-1513.
6. Belichenko N.P., Belichenko P.V., Li H.H., Mobley W.C., Francke U. Comparative study of brain morphology in Mecp2 mutant mouse models of Rett syndrome. J. Comp. Neurol. 2008, 508:184-195.
7. Belichenko N.P., Belichenko P.V., Mobley W.C. Evidence for both neuronal cell autonomous and nonautonomous effects of methyl-CpG-binding protein 2 in the cerebral cortex of female mice with Mecp2 mutation. Neurobiol. Dis. 2009, 34:71-77.
8. Belichenko P.V., Wright E.E., Belichenko N.P., Masliah E., Li H.H., Mobley W.C., Francke U. Widespread changes in dendritic and axonal morphology in Mecp2-mutant mouse models of Rett syndrome: evidence for disruption of neuronal networks. J. Comp. Neurol. 2009, 514:240-258.
9. Bienvenu T., Chelly J. Molecular genetics of Rett syndrome: when DNA methylation goes unrecognized. Nat. Rev. Genet. 2006, 7:415-426.
10. Brendel C., Belakhov V., Werner H., Wegener E., Gärtner J., Nudelman I., Baasov T., Huppke P. Readthrough of nonsense mutations in Rett syndrome: evaluation of novel aminoglycosides and generation of a new mouse model. J. Mol. Med. 2011, 89:389-398.
11. Chahrour M., Zoghbi H.Y. The story of Rett syndrome: from clinic to neurobiology. Neuron 2007, 56:422-437.
12. Chao H.-T., Zoghbi H.Y., Rosenmund C. MeCP2 controls excitatory synaptic strength by regulating glutamatergic synapse number. Neuron 2007, 56:58-65.
13. Chapleau C.A., Calfa G.D., Lane M.C., Albertson A.J., Larimore J.L., Kudo S., Armstrong D.L., Percy A.K., Pozzo-Miller L. Dendritic spine pathologies in hippocampal pyramidal neurons from Rett syndrome brain and after expression of Rett-associated MECP2 mutations. Neurobiol. Dis. 2009, 35:219-233.
14. Chapleau C.A., Boggio E.M., Calfa G., Percy A.K., Giustetto M., Pozzo-Miller L. Hippocampal CA1 pyramidal neurons of Mecp2 mutant mice show a dendritic spine phenotype only in the presymptomatic stage. Neural Plast. 2012, 2012:1-9.
15. Chen R.Z., Akbarian S., Tudor M., Jaenisch R. Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice. Nat. Genet. 2001, 27:327-331.
16. Cohen S., Gabel H.W., Hemberg M., Hutchinson A.N., Sadacca L.A., Ebert D.H., Harmin D.A., Greenberg R.S., Verdine V.K., Zhou Z., et al. Genome-wide activity-dependent MeCP2 phosphorylation regulates nervous system development and function. Neuron 2011, 72:72-85.
17. Collins A.L., Levenson J.M., Vilaythong A.P., Richman R., Armstrong D.L., Noebels J.L., David Sweatt J., Zoghbi H.Y. Mild overexpression of MeCP2 causes a progressive neurological disorder in mice. Hum. Mol. Genet. 2004, 13:2679-2689.
18. Dani V.S., Nelson S.B. Intact long-term potentiation but reduced connectivity between neocortical layer 5 pyramidal neurons in a mouse model of Rett syndrome. J. Neurosci. 2009, 29:11263-11270.
19. Feng G., Mellor R.H., Bernstein M., Keller-Peck C., Nguyen Q.T., Wallace M., Nerbonne J.M., Lichtman J.W., Sanes J.R. Imaging neuronal subsets in transgenic mice expressing multiple spectral variants of GFP. Neuron 2000, 28:41-51.
20. Fukuda T., Itoh M., Ichikawa T., Washiyama K., Goto Y.-I. Delayed maturation of neuronal architecture and synaptogenesis in cerebral cortex of Mecp2-deficient mice. J. Neuropathol. Exp. Neurol. 2005, 64:537-544.
21. Giacometti E., Luikenhuis S., Beard C., Jaenisch R. Partial rescue of MeCP2 deficiency by postnatal activation of MeCP2. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:1931-1936.
22. Goffin D., Zhou Z. The neural circuit basis of Rett syndrome. Front. Biol. 2012, 7:428-435.
23. Goffin D., Allen M., Zhang L., Amorim M., Wang I.-T.J., Reyes A.-R.S., Mercado-Berton A., Ong C., Cohen S., Hu L., et al. Rett syndrome mutation MeCP2 T158A disrupts DNA binding, protein stability and ERP responses. Nat. Neurosci. 2012, 15:274-283.
24. Guy J., Hendrich B., Holmes M., Martin J.E., Bird A. A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nat. Genet. 2001, 27:322-326.
25. Guy J., Gan J., Selfridge J., Cobb S., Bird A. Reversal of neurological defects in a mouse model of Rett syndrome. Science 2007, 315:1143-1147.
26. Jellinger K., Armstrong D., Zoghbi H.Y., Percy A.K. Neuropathology of Rett syndrome. Acta Neuropathol. 1988, 76:142-158.
27. Jentarra G.M., Olfers S.L., Rice S.G., Srivastava N., Homanics G.E., Blue M., Naidu S., Narayanan V. Abnormalities of cell packing density and dendritic complexity in the MeCP2 A140V mouse model of Rett syndrome/X-linked mental retardation. BMC Neurosci. 2010, 11:19.
28. Jugloff D.G.M., Jung B.P., Purushotham D., Logan R., Eubanks J.H. Increased dendritic complexity and axonal length in cultured mouse cortical neurons overexpressing methyl-CpG-binding protein MeCP2. Neurobiol. Dis. 2005, 19:18-27.
29. Katz D.M., Berger-Sweeney J.E., Eubanks J.H., Justice M.J., Neul J.L., Pozzo-Miller L., Blue M.E., Christian D., Crawley J.N., Giustetto M., et al. Preclinical research in Rett syndrome: setting the foundation for translational success. Dis. Model Mech. 2012, 5:733-745.
30. Kaufmann W.E., MacDonald S.M., Altamura C.R. Dendritic cytoskeletal protein expression in mental retardation: an immunohistochemical study of the neocortex in Rett syndrome. Cereb. Cortex 2000, 10:992-1004.
31. Kishi N., Macklis J.D. MECP2 is progressively expressed in post-migratory neurons and is involved in neuronal maturation rather than cell fate decisions. Mol. Cell. Neurosci. 2004, 27:306-321.
32. Kriaucionis S., Bird A. DNA methylation and Rett syndrome. Hum. Mol. Genet. 2003, 12(Spec No 2):R221-R227.
33. Larimore J.L., Chapleau C.A., Kudo S., Theibert A., Percy A.K., Pozzo-Miller L. Bdnf overexpression in hippocampal neurons prevents dendritic atrophy caused by Rett-associated MECP2 mutations. Neurobiol. Dis. 2009, 34:199-211.
34. Lioy D.T., Garg S.K., Monaghan C.E., Raber J., Foust K.D., Kaspar B.K., Hirrlinger P.G., Kirchhoff F., Bissonnette J.M., Ballas N., et al. A role for glia in the progression of Rett's syndrome. Nature 2011, 475:497-500.
35. Luikenhuis S., Giacometti E., Beard C.F., Jaenisch R. Expression of MeCP2 in postmitotic neurons rescues Rett syndrome in mice. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:6033-6038.
36. Marchetto M.C.N., Carromeu C., Acab A., Yu D., Yeo G.W., Mu Y., Chen G., Gage F.H., Muotri A.R. A model for neural development and treatment of Rett syndrome using human induced pluripotent stem cells. Cell 2010, 143:527-539.
37. Marshak S., Meynard M.M., De Vries Y.A., Kidane A.H., Cohen-Cory S. Cell-autonomous alterations in dendritic arbor morphology and connectivity induced by overexpression of MeCP2 in xenopus central neurons in vivo. PLoS One 2012, 7:e33153.
38. Meijering E., Jacob M., Sarria J.-C.F., Steiner P., Hirling H., Unser M. Design and validation of a tool for neurite tracing and analysis in fluorescence microscopy images. Cytometry A 2004, 58:167-176.
39. Metcalf B.M., Mullaney B.C., Johnston M.V., Blue M.E. Temporal shift in methyl-CpG binding protein 2 expression in a mouse model of Rett syndrome. Neuroscience 2006, 139:1449-1460.
40. Moretti P., Levenson J.M., Battaglia F., Atkinson R., Teague R., Antalffy B., Armstrong D., Arancio O., Sweatt J.D., Zoghbi H.Y. Learning and memory and synaptic plasticity are impaired in a mouse model of Rett syndrome. J. Neurosci. 2006, 26:319-327.
41. Na E.S., Nelson E.D., Adachi M., Autry A.E., Mahgoub M.A., Kavalali E.T., Monteggia L.M. A mouse model for MeCP2 duplication syndrome: MeCP2 overexpression impairs learning and memory and synaptic transmission. J. Neurosci. 2012, 32:3109-3117.
42. Pelka G.J., Watson C.M., Radziewic T., Hayward M., Lahooti H., Christodoulou J., Tam P.P.L. Mecp2 deficiency is associated with learning and cognitive deficits and altered gene activity in the hippocampal region of mice. Brain 2006, 129:887-898.
43. Ramocki M.B., Peters S.U., Tavyev Y.J., Zhang F., Carvalho C.M.B., Schaaf C.P., Richman R., Fang P., Glaze D.G., Lupski J.R., et al. Autism and other neuropsychiatric symptoms are prevalent in individuals with MeCP2 duplication syndrome. Ann. Neurol. 2009, 66:771-782.
44. Robinson L., Guy J., McKay L., Brockett E., Spike R.C., Selfridge J., De Sousa D., Merusi C., Riedel G., Bird A., et al. Morphological and functional reversal of phenotypes in a mouse model of Rett syndrome. Brain 2012, 135:2699-2710.
45. Samaco R.C., Mandel-Brehm C., McGraw C.M., Shaw C.A., McGill B.E., Zoghbi H.Y. Crh and Oprm1 mediate anxiety-related behavior and social approach in a mouse model of MECP2 duplication syndrome. Nat. Genet. 2012, 44:206-211.
46. Shahbazian M., Young J., Yuva-Paylor L., Spencer C., Antalffy B., Noebels J., Armstrong D., Paylor R., Zoghbi H. Mice with truncated MeCP2 recapitulate many Rett syndrome features and display hyperacetylation of histone H3. Neuron 2002, 35:243-254.
47. Sholl D.A. Dendritic organization in the neurons of the visual and motor cortices of the cat. J. Anat. 1953, 87:387-406.
48. Smrt R.D., Eaves-Egenes J., Barkho B.Z., Santistevan N.J., Zhao C., Aimone J.B., Gage F.H., Zhao X. Mecp2 deficiency leads to delayed maturation and altered gene expression in hippocampal neurons. Neurobiol. Dis. 2007, 27:77-89.
49. Spruston N. Pyramidal neurons: dendritic structure and synaptic integration. Nat. Rev. Neurosci. 2008, 9:206-221.
50. Stuss D.P., Boyd J.D., Levin D.B., Delaney K.R. MeCP2 mutation results in compartment-specific reductions in dendritic branching and spine density in layer 5 motor cortical neurons of YFP-H mice. PLoS One 2012, 7:e31896.
51. Taneja P., Ogier M., Brooks-Harris G., Schmid D.A., Katz D.M., Nelson S.B. Pathophysiology of locus ceruleus neurons in a mouse model of Rett syndrome. J. Neurosci. 2009, 29:12187-12195.
52. Tropea D., Giacometti E., Wilson N.R., Beard C., McCurry C., Fu D.D., Flannery R., Jaenisch R., Sur M. Partial reversal of Rett syndrome-like symptoms in MeCP2 mutant mice. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:2029-2034.
53. Van Esch H., Jansen A., Bauters M., Froyen G., Fryns J.-P. Encephalopathy and bilateral cataract in a boy with an interstitial deletion of Xp22 comprising the CDKL5 and NHS genes. Am. J. Med. Genet. A 2007, 143:364-369.
54. Vonhoff F., Williams A., Ryglewski S., Duch C. Drosophila as a model for MECP2 gain of function in neurons. PLoS One 2012, 7:e31835.
55. Yazdani M., Deogracias R., Guy J., Poot R.A., Bird A., Barde Y.-A. Disease modeling using embryonic stem cells: MeCP2 regulates nuclear size and RNA synthesis in neurons. Stem Cells 2012, 30:2128-2139.
56. Zhou Z., Hong E.J., Cohen S., Zhao W.-N., Ho H.-Y.H., Schmidt L., Chen W.G., Lin Y., Savner E., Griffith E.C., et al. Brain-specific phosphorylation of MeCP2 regulates activity-dependent Bdnf transcription, dendritic growth, and spine maturation. Neuron 2006, 52:255-269.